Global Invasive Candidiasis Treatment Drug Supply, Demand and Key Producers, 2023-2029
The global Invasive Candidiasis Treatment Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Invasive Candidiasis Treatment Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Invasive Candidiasis Treatment Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Invasive Candidiasis Treatment Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Invasive Candidiasis Treatment Drug total market, 2018-2029, (USD Million)
Global Invasive Candidiasis Treatment Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Invasive Candidiasis Treatment Drug total market, key domestic companies and share, (USD Million)
Global Invasive Candidiasis Treatment Drug revenue by player and market share 2018-2023, (USD Million)
Global Invasive Candidiasis Treatment Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Invasive Candidiasis Treatment Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Invasive Candidiasis Treatment Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Merck & Co., Inc, Pfizer Inc, Cidara Therapeutics, Inc, Astellas Pharma Inc, Gilead Sciences, Inc, Novo Nordisk A/S (Xellia Pharmaceuticals), Biosergen AB and Matinas BioPharma Holdings, Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Invasive Candidiasis Treatment Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Invasive Candidiasis Treatment Drug Market, By Region:
1. How big is the global Invasive Candidiasis Treatment Drug market?
2. What is the demand of the global Invasive Candidiasis Treatment Drug market?
3. What is the year over year growth of the global Invasive Candidiasis Treatment Drug market?
4. What is the total value of the global Invasive Candidiasis Treatment Drug market?
5. Who are the major players in the global Invasive Candidiasis Treatment Drug market?
6. What are the growth factors driving the market demand?
This report studies the global Invasive Candidiasis Treatment Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Invasive Candidiasis Treatment Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Invasive Candidiasis Treatment Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Invasive Candidiasis Treatment Drug total market, 2018-2029, (USD Million)
Global Invasive Candidiasis Treatment Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Invasive Candidiasis Treatment Drug total market, key domestic companies and share, (USD Million)
Global Invasive Candidiasis Treatment Drug revenue by player and market share 2018-2023, (USD Million)
Global Invasive Candidiasis Treatment Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Invasive Candidiasis Treatment Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Invasive Candidiasis Treatment Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Merck & Co., Inc, Pfizer Inc, Cidara Therapeutics, Inc, Astellas Pharma Inc, Gilead Sciences, Inc, Novo Nordisk A/S (Xellia Pharmaceuticals), Biosergen AB and Matinas BioPharma Holdings, Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Invasive Candidiasis Treatment Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Invasive Candidiasis Treatment Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Azoles Drug
- Echinocandins Drug
- Allylamines Drug
- Polyenes Drug
- Others
- Hospital
- Clinic
- Others
- GlaxoSmithKline
- Merck & Co., Inc
- Pfizer Inc
- Cidara Therapeutics, Inc
- Astellas Pharma Inc
- Gilead Sciences, Inc
- Novo Nordisk A/S (Xellia Pharmaceuticals)
- Biosergen AB
- Matinas BioPharma Holdings, Inc
- Pulmocide Ltd
- F2G Ltd
1. How big is the global Invasive Candidiasis Treatment Drug market?
2. What is the demand of the global Invasive Candidiasis Treatment Drug market?
3. What is the year over year growth of the global Invasive Candidiasis Treatment Drug market?
4. What is the total value of the global Invasive Candidiasis Treatment Drug market?
5. Who are the major players in the global Invasive Candidiasis Treatment Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Invasive Candidiasis Treatment Drug Introduction
1.2 World Invasive Candidiasis Treatment Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Invasive Candidiasis Treatment Drug Total Market by Region (by Headquarter Location)
1.3.1 World Invasive Candidiasis Treatment Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Invasive Candidiasis Treatment Drug Market Size (2018-2029)
1.3.3 China Invasive Candidiasis Treatment Drug Market Size (2018-2029)
1.3.4 Europe Invasive Candidiasis Treatment Drug Market Size (2018-2029)
1.3.5 Japan Invasive Candidiasis Treatment Drug Market Size (2018-2029)
1.3.6 South Korea Invasive Candidiasis Treatment Drug Market Size (2018-2029)
1.3.7 ASEAN Invasive Candidiasis Treatment Drug Market Size (2018-2029)
1.3.8 India Invasive Candidiasis Treatment Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Invasive Candidiasis Treatment Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Invasive Candidiasis Treatment Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
2.2 World Invasive Candidiasis Treatment Drug Consumption Value by Region
2.2.1 World Invasive Candidiasis Treatment Drug Consumption Value by Region (2018-2023)
2.2.2 World Invasive Candidiasis Treatment Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
2.4 China Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
2.5 Europe Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
2.6 Japan Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
2.7 South Korea Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
2.8 ASEAN Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
2.9 India Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
3 WORLD INVASIVE CANDIDIASIS TREATMENT DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Invasive Candidiasis Treatment Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Invasive Candidiasis Treatment Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Invasive Candidiasis Treatment Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Invasive Candidiasis Treatment Drug in 2022
3.3 Invasive Candidiasis Treatment Drug Company Evaluation Quadrant
3.4 Invasive Candidiasis Treatment Drug Market: Overall Company Footprint Analysis
3.4.1 Invasive Candidiasis Treatment Drug Market: Region Footprint
3.4.2 Invasive Candidiasis Treatment Drug Market: Company Product Type Footprint
3.4.3 Invasive Candidiasis Treatment Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Invasive Candidiasis Treatment Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Invasive Candidiasis Treatment Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Invasive Candidiasis Treatment Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Invasive Candidiasis Treatment Drug Consumption Value Comparison
4.2.1 United States VS China: Invasive Candidiasis Treatment Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Invasive Candidiasis Treatment Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Invasive Candidiasis Treatment Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Invasive Candidiasis Treatment Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Invasive Candidiasis Treatment Drug Revenue, (2018-2023)
4.4 China Based Companies Invasive Candidiasis Treatment Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Invasive Candidiasis Treatment Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Invasive Candidiasis Treatment Drug Revenue, (2018-2023)
4.5 Rest of World Based Invasive Candidiasis Treatment Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Invasive Candidiasis Treatment Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Invasive Candidiasis Treatment Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Invasive Candidiasis Treatment Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Azoles Drug
5.2.2 Echinocandins Drug
5.2.3 Allylamines Drug
5.2.4 Polyenes Drug
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Invasive Candidiasis Treatment Drug Market Size by Type (2018-2023)
5.3.2 World Invasive Candidiasis Treatment Drug Market Size by Type (2024-2029)
5.3.3 World Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Invasive Candidiasis Treatment Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Invasive Candidiasis Treatment Drug Market Size by Application (2018-2023)
6.3.2 World Invasive Candidiasis Treatment Drug Market Size by Application (2024-2029)
6.3.3 World Invasive Candidiasis Treatment Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Details
7.1.2 GlaxoSmithKline Major Business
7.1.3 GlaxoSmithKline Invasive Candidiasis Treatment Drug Product and Services
7.1.4 GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 GlaxoSmithKline Recent Developments/Updates
7.1.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.2 Merck & Co., Inc
7.2.1 Merck & Co., Inc Details
7.2.2 Merck & Co., Inc Major Business
7.2.3 Merck & Co., Inc Invasive Candidiasis Treatment Drug Product and Services
7.2.4 Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Merck & Co., Inc Recent Developments/Updates
7.2.6 Merck & Co., Inc Competitive Strengths & Weaknesses
7.3 Pfizer Inc
7.3.1 Pfizer Inc Details
7.3.2 Pfizer Inc Major Business
7.3.3 Pfizer Inc Invasive Candidiasis Treatment Drug Product and Services
7.3.4 Pfizer Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Inc Recent Developments/Updates
7.3.6 Pfizer Inc Competitive Strengths & Weaknesses
7.4 Cidara Therapeutics, Inc
7.4.1 Cidara Therapeutics, Inc Details
7.4.2 Cidara Therapeutics, Inc Major Business
7.4.3 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product and Services
7.4.4 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Cidara Therapeutics, Inc Recent Developments/Updates
7.4.6 Cidara Therapeutics, Inc Competitive Strengths & Weaknesses
7.5 Astellas Pharma Inc
7.5.1 Astellas Pharma Inc Details
7.5.2 Astellas Pharma Inc Major Business
7.5.3 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product and Services
7.5.4 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Astellas Pharma Inc Recent Developments/Updates
7.5.6 Astellas Pharma Inc Competitive Strengths & Weaknesses
7.6 Gilead Sciences, Inc
7.6.1 Gilead Sciences, Inc Details
7.6.2 Gilead Sciences, Inc Major Business
7.6.3 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product and Services
7.6.4 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Gilead Sciences, Inc Recent Developments/Updates
7.6.6 Gilead Sciences, Inc Competitive Strengths & Weaknesses
7.7 Novo Nordisk A/S (Xellia Pharmaceuticals)
7.7.1 Novo Nordisk A/S (Xellia Pharmaceuticals) Details
7.7.2 Novo Nordisk A/S (Xellia Pharmaceuticals) Major Business
7.7.3 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product and Services
7.7.4 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Developments/Updates
7.7.6 Novo Nordisk A/S (Xellia Pharmaceuticals) Competitive Strengths & Weaknesses
7.8 Biosergen AB
7.8.1 Biosergen AB Details
7.8.2 Biosergen AB Major Business
7.8.3 Biosergen AB Invasive Candidiasis Treatment Drug Product and Services
7.8.4 Biosergen AB Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Biosergen AB Recent Developments/Updates
7.8.6 Biosergen AB Competitive Strengths & Weaknesses
7.9 Matinas BioPharma Holdings, Inc
7.9.1 Matinas BioPharma Holdings, Inc Details
7.9.2 Matinas BioPharma Holdings, Inc Major Business
7.9.3 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product and Services
7.9.4 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Matinas BioPharma Holdings, Inc Recent Developments/Updates
7.9.6 Matinas BioPharma Holdings, Inc Competitive Strengths & Weaknesses
7.10 Pulmocide Ltd
7.10.1 Pulmocide Ltd Details
7.10.2 Pulmocide Ltd Major Business
7.10.3 Pulmocide Ltd Invasive Candidiasis Treatment Drug Product and Services
7.10.4 Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Pulmocide Ltd Recent Developments/Updates
7.10.6 Pulmocide Ltd Competitive Strengths & Weaknesses
7.11 F2G Ltd
7.11.1 F2G Ltd Details
7.11.2 F2G Ltd Major Business
7.11.3 F2G Ltd Invasive Candidiasis Treatment Drug Product and Services
7.11.4 F2G Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 F2G Ltd Recent Developments/Updates
7.11.6 F2G Ltd Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Invasive Candidiasis Treatment Drug Industry Chain
8.2 Invasive Candidiasis Treatment Drug Upstream Analysis
8.3 Invasive Candidiasis Treatment Drug Midstream Analysis
8.4 Invasive Candidiasis Treatment Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Invasive Candidiasis Treatment Drug Introduction
1.2 World Invasive Candidiasis Treatment Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Invasive Candidiasis Treatment Drug Total Market by Region (by Headquarter Location)
1.3.1 World Invasive Candidiasis Treatment Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Invasive Candidiasis Treatment Drug Market Size (2018-2029)
1.3.3 China Invasive Candidiasis Treatment Drug Market Size (2018-2029)
1.3.4 Europe Invasive Candidiasis Treatment Drug Market Size (2018-2029)
1.3.5 Japan Invasive Candidiasis Treatment Drug Market Size (2018-2029)
1.3.6 South Korea Invasive Candidiasis Treatment Drug Market Size (2018-2029)
1.3.7 ASEAN Invasive Candidiasis Treatment Drug Market Size (2018-2029)
1.3.8 India Invasive Candidiasis Treatment Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Invasive Candidiasis Treatment Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Invasive Candidiasis Treatment Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
2.2 World Invasive Candidiasis Treatment Drug Consumption Value by Region
2.2.1 World Invasive Candidiasis Treatment Drug Consumption Value by Region (2018-2023)
2.2.2 World Invasive Candidiasis Treatment Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
2.4 China Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
2.5 Europe Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
2.6 Japan Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
2.7 South Korea Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
2.8 ASEAN Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
2.9 India Invasive Candidiasis Treatment Drug Consumption Value (2018-2029)
3 WORLD INVASIVE CANDIDIASIS TREATMENT DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Invasive Candidiasis Treatment Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Invasive Candidiasis Treatment Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Invasive Candidiasis Treatment Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Invasive Candidiasis Treatment Drug in 2022
3.3 Invasive Candidiasis Treatment Drug Company Evaluation Quadrant
3.4 Invasive Candidiasis Treatment Drug Market: Overall Company Footprint Analysis
3.4.1 Invasive Candidiasis Treatment Drug Market: Region Footprint
3.4.2 Invasive Candidiasis Treatment Drug Market: Company Product Type Footprint
3.4.3 Invasive Candidiasis Treatment Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Invasive Candidiasis Treatment Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Invasive Candidiasis Treatment Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Invasive Candidiasis Treatment Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Invasive Candidiasis Treatment Drug Consumption Value Comparison
4.2.1 United States VS China: Invasive Candidiasis Treatment Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Invasive Candidiasis Treatment Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Invasive Candidiasis Treatment Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Invasive Candidiasis Treatment Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Invasive Candidiasis Treatment Drug Revenue, (2018-2023)
4.4 China Based Companies Invasive Candidiasis Treatment Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Invasive Candidiasis Treatment Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Invasive Candidiasis Treatment Drug Revenue, (2018-2023)
4.5 Rest of World Based Invasive Candidiasis Treatment Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Invasive Candidiasis Treatment Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Invasive Candidiasis Treatment Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Invasive Candidiasis Treatment Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Azoles Drug
5.2.2 Echinocandins Drug
5.2.3 Allylamines Drug
5.2.4 Polyenes Drug
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Invasive Candidiasis Treatment Drug Market Size by Type (2018-2023)
5.3.2 World Invasive Candidiasis Treatment Drug Market Size by Type (2024-2029)
5.3.3 World Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Invasive Candidiasis Treatment Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Invasive Candidiasis Treatment Drug Market Size by Application (2018-2023)
6.3.2 World Invasive Candidiasis Treatment Drug Market Size by Application (2024-2029)
6.3.3 World Invasive Candidiasis Treatment Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Details
7.1.2 GlaxoSmithKline Major Business
7.1.3 GlaxoSmithKline Invasive Candidiasis Treatment Drug Product and Services
7.1.4 GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 GlaxoSmithKline Recent Developments/Updates
7.1.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.2 Merck & Co., Inc
7.2.1 Merck & Co., Inc Details
7.2.2 Merck & Co., Inc Major Business
7.2.3 Merck & Co., Inc Invasive Candidiasis Treatment Drug Product and Services
7.2.4 Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Merck & Co., Inc Recent Developments/Updates
7.2.6 Merck & Co., Inc Competitive Strengths & Weaknesses
7.3 Pfizer Inc
7.3.1 Pfizer Inc Details
7.3.2 Pfizer Inc Major Business
7.3.3 Pfizer Inc Invasive Candidiasis Treatment Drug Product and Services
7.3.4 Pfizer Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Inc Recent Developments/Updates
7.3.6 Pfizer Inc Competitive Strengths & Weaknesses
7.4 Cidara Therapeutics, Inc
7.4.1 Cidara Therapeutics, Inc Details
7.4.2 Cidara Therapeutics, Inc Major Business
7.4.3 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product and Services
7.4.4 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Cidara Therapeutics, Inc Recent Developments/Updates
7.4.6 Cidara Therapeutics, Inc Competitive Strengths & Weaknesses
7.5 Astellas Pharma Inc
7.5.1 Astellas Pharma Inc Details
7.5.2 Astellas Pharma Inc Major Business
7.5.3 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product and Services
7.5.4 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Astellas Pharma Inc Recent Developments/Updates
7.5.6 Astellas Pharma Inc Competitive Strengths & Weaknesses
7.6 Gilead Sciences, Inc
7.6.1 Gilead Sciences, Inc Details
7.6.2 Gilead Sciences, Inc Major Business
7.6.3 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product and Services
7.6.4 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Gilead Sciences, Inc Recent Developments/Updates
7.6.6 Gilead Sciences, Inc Competitive Strengths & Weaknesses
7.7 Novo Nordisk A/S (Xellia Pharmaceuticals)
7.7.1 Novo Nordisk A/S (Xellia Pharmaceuticals) Details
7.7.2 Novo Nordisk A/S (Xellia Pharmaceuticals) Major Business
7.7.3 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product and Services
7.7.4 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Developments/Updates
7.7.6 Novo Nordisk A/S (Xellia Pharmaceuticals) Competitive Strengths & Weaknesses
7.8 Biosergen AB
7.8.1 Biosergen AB Details
7.8.2 Biosergen AB Major Business
7.8.3 Biosergen AB Invasive Candidiasis Treatment Drug Product and Services
7.8.4 Biosergen AB Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Biosergen AB Recent Developments/Updates
7.8.6 Biosergen AB Competitive Strengths & Weaknesses
7.9 Matinas BioPharma Holdings, Inc
7.9.1 Matinas BioPharma Holdings, Inc Details
7.9.2 Matinas BioPharma Holdings, Inc Major Business
7.9.3 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product and Services
7.9.4 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Matinas BioPharma Holdings, Inc Recent Developments/Updates
7.9.6 Matinas BioPharma Holdings, Inc Competitive Strengths & Weaknesses
7.10 Pulmocide Ltd
7.10.1 Pulmocide Ltd Details
7.10.2 Pulmocide Ltd Major Business
7.10.3 Pulmocide Ltd Invasive Candidiasis Treatment Drug Product and Services
7.10.4 Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Pulmocide Ltd Recent Developments/Updates
7.10.6 Pulmocide Ltd Competitive Strengths & Weaknesses
7.11 F2G Ltd
7.11.1 F2G Ltd Details
7.11.2 F2G Ltd Major Business
7.11.3 F2G Ltd Invasive Candidiasis Treatment Drug Product and Services
7.11.4 F2G Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 F2G Ltd Recent Developments/Updates
7.11.6 F2G Ltd Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Invasive Candidiasis Treatment Drug Industry Chain
8.2 Invasive Candidiasis Treatment Drug Upstream Analysis
8.3 Invasive Candidiasis Treatment Drug Midstream Analysis
8.4 Invasive Candidiasis Treatment Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Invasive Candidiasis Treatment Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Invasive Candidiasis Treatment Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Invasive Candidiasis Treatment Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Invasive Candidiasis Treatment Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Invasive Candidiasis Treatment Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Invasive Candidiasis Treatment Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Invasive Candidiasis Treatment Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Invasive Candidiasis Treatment Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Invasive Candidiasis Treatment Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Invasive Candidiasis Treatment Drug Players in 2022
Table 12. World Invasive Candidiasis Treatment Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Invasive Candidiasis Treatment Drug Company Evaluation Quadrant
Table 14. Head Office of Key Invasive Candidiasis Treatment Drug Player
Table 15. Invasive Candidiasis Treatment Drug Market: Company Product Type Footprint
Table 16. Invasive Candidiasis Treatment Drug Market: Company Product Application Footprint
Table 17. Invasive Candidiasis Treatment Drug Mergers & Acquisitions Activity
Table 18. United States VS China Invasive Candidiasis Treatment Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Invasive Candidiasis Treatment Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Invasive Candidiasis Treatment Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Invasive Candidiasis Treatment Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Invasive Candidiasis Treatment Drug Revenue Market Share (2018-2023)
Table 23. China Based Invasive Candidiasis Treatment Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Invasive Candidiasis Treatment Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Invasive Candidiasis Treatment Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Invasive Candidiasis Treatment Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Invasive Candidiasis Treatment Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Invasive Candidiasis Treatment Drug Revenue Market Share (2018-2023)
Table 29. World Invasive Candidiasis Treatment Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Invasive Candidiasis Treatment Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Invasive Candidiasis Treatment Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Invasive Candidiasis Treatment Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Invasive Candidiasis Treatment Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Invasive Candidiasis Treatment Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. GlaxoSmithKline Basic Information, Area Served and Competitors
Table 36. GlaxoSmithKline Major Business
Table 37. GlaxoSmithKline Invasive Candidiasis Treatment Drug Product and Services
Table 38. GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. GlaxoSmithKline Recent Developments/Updates
Table 40. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 41. Merck & Co., Inc Basic Information, Area Served and Competitors
Table 42. Merck & Co., Inc Major Business
Table 43. Merck & Co., Inc Invasive Candidiasis Treatment Drug Product and Services
Table 44. Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Merck & Co., Inc Recent Developments/Updates
Table 46. Merck & Co., Inc Competitive Strengths & Weaknesses
Table 47. Pfizer Inc Basic Information, Area Served and Competitors
Table 48. Pfizer Inc Major Business
Table 49. Pfizer Inc Invasive Candidiasis Treatment Drug Product and Services
Table 50. Pfizer Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Pfizer Inc Recent Developments/Updates
Table 52. Pfizer Inc Competitive Strengths & Weaknesses
Table 53. Cidara Therapeutics, Inc Basic Information, Area Served and Competitors
Table 54. Cidara Therapeutics, Inc Major Business
Table 55. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product and Services
Table 56. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Cidara Therapeutics, Inc Recent Developments/Updates
Table 58. Cidara Therapeutics, Inc Competitive Strengths & Weaknesses
Table 59. Astellas Pharma Inc Basic Information, Area Served and Competitors
Table 60. Astellas Pharma Inc Major Business
Table 61. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product and Services
Table 62. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Astellas Pharma Inc Recent Developments/Updates
Table 64. Astellas Pharma Inc Competitive Strengths & Weaknesses
Table 65. Gilead Sciences, Inc Basic Information, Area Served and Competitors
Table 66. Gilead Sciences, Inc Major Business
Table 67. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product and Services
Table 68. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Gilead Sciences, Inc Recent Developments/Updates
Table 70. Gilead Sciences, Inc Competitive Strengths & Weaknesses
Table 71. Novo Nordisk A/S (Xellia Pharmaceuticals) Basic Information, Area Served and Competitors
Table 72. Novo Nordisk A/S (Xellia Pharmaceuticals) Major Business
Table 73. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product and Services
Table 74. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Developments/Updates
Table 76. Novo Nordisk A/S (Xellia Pharmaceuticals) Competitive Strengths & Weaknesses
Table 77. Biosergen AB Basic Information, Area Served and Competitors
Table 78. Biosergen AB Major Business
Table 79. Biosergen AB Invasive Candidiasis Treatment Drug Product and Services
Table 80. Biosergen AB Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Biosergen AB Recent Developments/Updates
Table 82. Biosergen AB Competitive Strengths & Weaknesses
Table 83. Matinas BioPharma Holdings, Inc Basic Information, Area Served and Competitors
Table 84. Matinas BioPharma Holdings, Inc Major Business
Table 85. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product and Services
Table 86. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Matinas BioPharma Holdings, Inc Recent Developments/Updates
Table 88. Matinas BioPharma Holdings, Inc Competitive Strengths & Weaknesses
Table 89. Pulmocide Ltd Basic Information, Area Served and Competitors
Table 90. Pulmocide Ltd Major Business
Table 91. Pulmocide Ltd Invasive Candidiasis Treatment Drug Product and Services
Table 92. Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Pulmocide Ltd Recent Developments/Updates
Table 94. F2G Ltd Basic Information, Area Served and Competitors
Table 95. F2G Ltd Major Business
Table 96. F2G Ltd Invasive Candidiasis Treatment Drug Product and Services
Table 97. F2G Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Invasive Candidiasis Treatment Drug Upstream (Raw Materials)
Table 99. Invasive Candidiasis Treatment Drug Typical Customers
Table 1. World Invasive Candidiasis Treatment Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Invasive Candidiasis Treatment Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Invasive Candidiasis Treatment Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Invasive Candidiasis Treatment Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Invasive Candidiasis Treatment Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Invasive Candidiasis Treatment Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Invasive Candidiasis Treatment Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Invasive Candidiasis Treatment Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Invasive Candidiasis Treatment Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Invasive Candidiasis Treatment Drug Players in 2022
Table 12. World Invasive Candidiasis Treatment Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Invasive Candidiasis Treatment Drug Company Evaluation Quadrant
Table 14. Head Office of Key Invasive Candidiasis Treatment Drug Player
Table 15. Invasive Candidiasis Treatment Drug Market: Company Product Type Footprint
Table 16. Invasive Candidiasis Treatment Drug Market: Company Product Application Footprint
Table 17. Invasive Candidiasis Treatment Drug Mergers & Acquisitions Activity
Table 18. United States VS China Invasive Candidiasis Treatment Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Invasive Candidiasis Treatment Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Invasive Candidiasis Treatment Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Invasive Candidiasis Treatment Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Invasive Candidiasis Treatment Drug Revenue Market Share (2018-2023)
Table 23. China Based Invasive Candidiasis Treatment Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Invasive Candidiasis Treatment Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Invasive Candidiasis Treatment Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Invasive Candidiasis Treatment Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Invasive Candidiasis Treatment Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Invasive Candidiasis Treatment Drug Revenue Market Share (2018-2023)
Table 29. World Invasive Candidiasis Treatment Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Invasive Candidiasis Treatment Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Invasive Candidiasis Treatment Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Invasive Candidiasis Treatment Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Invasive Candidiasis Treatment Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Invasive Candidiasis Treatment Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. GlaxoSmithKline Basic Information, Area Served and Competitors
Table 36. GlaxoSmithKline Major Business
Table 37. GlaxoSmithKline Invasive Candidiasis Treatment Drug Product and Services
Table 38. GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. GlaxoSmithKline Recent Developments/Updates
Table 40. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 41. Merck & Co., Inc Basic Information, Area Served and Competitors
Table 42. Merck & Co., Inc Major Business
Table 43. Merck & Co., Inc Invasive Candidiasis Treatment Drug Product and Services
Table 44. Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Merck & Co., Inc Recent Developments/Updates
Table 46. Merck & Co., Inc Competitive Strengths & Weaknesses
Table 47. Pfizer Inc Basic Information, Area Served and Competitors
Table 48. Pfizer Inc Major Business
Table 49. Pfizer Inc Invasive Candidiasis Treatment Drug Product and Services
Table 50. Pfizer Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Pfizer Inc Recent Developments/Updates
Table 52. Pfizer Inc Competitive Strengths & Weaknesses
Table 53. Cidara Therapeutics, Inc Basic Information, Area Served and Competitors
Table 54. Cidara Therapeutics, Inc Major Business
Table 55. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product and Services
Table 56. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Cidara Therapeutics, Inc Recent Developments/Updates
Table 58. Cidara Therapeutics, Inc Competitive Strengths & Weaknesses
Table 59. Astellas Pharma Inc Basic Information, Area Served and Competitors
Table 60. Astellas Pharma Inc Major Business
Table 61. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product and Services
Table 62. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Astellas Pharma Inc Recent Developments/Updates
Table 64. Astellas Pharma Inc Competitive Strengths & Weaknesses
Table 65. Gilead Sciences, Inc Basic Information, Area Served and Competitors
Table 66. Gilead Sciences, Inc Major Business
Table 67. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product and Services
Table 68. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Gilead Sciences, Inc Recent Developments/Updates
Table 70. Gilead Sciences, Inc Competitive Strengths & Weaknesses
Table 71. Novo Nordisk A/S (Xellia Pharmaceuticals) Basic Information, Area Served and Competitors
Table 72. Novo Nordisk A/S (Xellia Pharmaceuticals) Major Business
Table 73. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product and Services
Table 74. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Developments/Updates
Table 76. Novo Nordisk A/S (Xellia Pharmaceuticals) Competitive Strengths & Weaknesses
Table 77. Biosergen AB Basic Information, Area Served and Competitors
Table 78. Biosergen AB Major Business
Table 79. Biosergen AB Invasive Candidiasis Treatment Drug Product and Services
Table 80. Biosergen AB Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Biosergen AB Recent Developments/Updates
Table 82. Biosergen AB Competitive Strengths & Weaknesses
Table 83. Matinas BioPharma Holdings, Inc Basic Information, Area Served and Competitors
Table 84. Matinas BioPharma Holdings, Inc Major Business
Table 85. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product and Services
Table 86. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Matinas BioPharma Holdings, Inc Recent Developments/Updates
Table 88. Matinas BioPharma Holdings, Inc Competitive Strengths & Weaknesses
Table 89. Pulmocide Ltd Basic Information, Area Served and Competitors
Table 90. Pulmocide Ltd Major Business
Table 91. Pulmocide Ltd Invasive Candidiasis Treatment Drug Product and Services
Table 92. Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Pulmocide Ltd Recent Developments/Updates
Table 94. F2G Ltd Basic Information, Area Served and Competitors
Table 95. F2G Ltd Major Business
Table 96. F2G Ltd Invasive Candidiasis Treatment Drug Product and Services
Table 97. F2G Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Invasive Candidiasis Treatment Drug Upstream (Raw Materials)
Table 99. Invasive Candidiasis Treatment Drug Typical Customers
LIST OF FIGURES
Figure 1. Invasive Candidiasis Treatment Drug Picture
Figure 2. World Invasive Candidiasis Treatment Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Invasive Candidiasis Treatment Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Invasive Candidiasis Treatment Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Invasive Candidiasis Treatment Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Invasive Candidiasis Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Invasive Candidiasis Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Invasive Candidiasis Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Invasive Candidiasis Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Invasive Candidiasis Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Invasive Candidiasis Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Invasive Candidiasis Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 13. Invasive Candidiasis Treatment Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Invasive Candidiasis Treatment Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Invasive Candidiasis Treatment Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Invasive Candidiasis Treatment Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Invasive Candidiasis Treatment Drug Markets in 2022
Figure 27. United States VS China: Invasive Candidiasis Treatment Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Invasive Candidiasis Treatment Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Invasive Candidiasis Treatment Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Invasive Candidiasis Treatment Drug Market Size Market Share by Type in 2022
Figure 31. Azoles Drug
Figure 32. Echinocandins Drug
Figure 33. Allylamines Drug
Figure 34. Polyenes Drug
Figure 35. Others
Figure 36. World Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2018-2029)
Figure 37. World Invasive Candidiasis Treatment Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Invasive Candidiasis Treatment Drug Market Size Market Share by Application in 2022
Figure 39. Hospital
Figure 40. Clinic
Figure 41. Others
Figure 42. Invasive Candidiasis Treatment Drug Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Invasive Candidiasis Treatment Drug Picture
Figure 2. World Invasive Candidiasis Treatment Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Invasive Candidiasis Treatment Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Invasive Candidiasis Treatment Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Invasive Candidiasis Treatment Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Invasive Candidiasis Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Invasive Candidiasis Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Invasive Candidiasis Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Invasive Candidiasis Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Invasive Candidiasis Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Invasive Candidiasis Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Invasive Candidiasis Treatment Drug Revenue (2018-2029) & (USD Million)
Figure 13. Invasive Candidiasis Treatment Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Invasive Candidiasis Treatment Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Invasive Candidiasis Treatment Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Invasive Candidiasis Treatment Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Invasive Candidiasis Treatment Drug Markets in 2022
Figure 27. United States VS China: Invasive Candidiasis Treatment Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Invasive Candidiasis Treatment Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Invasive Candidiasis Treatment Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Invasive Candidiasis Treatment Drug Market Size Market Share by Type in 2022
Figure 31. Azoles Drug
Figure 32. Echinocandins Drug
Figure 33. Allylamines Drug
Figure 34. Polyenes Drug
Figure 35. Others
Figure 36. World Invasive Candidiasis Treatment Drug Market Size Market Share by Type (2018-2029)
Figure 37. World Invasive Candidiasis Treatment Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Invasive Candidiasis Treatment Drug Market Size Market Share by Application in 2022
Figure 39. Hospital
Figure 40. Clinic
Figure 41. Others
Figure 42. Invasive Candidiasis Treatment Drug Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
